SciClone Pharmaceuticals, Inc.
(NASDAQ : SCLN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.04%172.250.7%$1088.53m
PFEPfizer Inc. -0.02%42.780.9%$1062.98m
AZNAstraZeneca Plc -0.69%57.241.0%$983.21m
MRKMerck & Co., Inc. -0.13%76.830.7%$651.89m
ABBVAbbVie, Inc. -2.22%116.231.9%$651.72m
BMYBristol-Myers Squibb Co. -0.34%67.921.0%$580.36m
LLYEli Lilly & Co. -0.80%243.361.1%$577.91m
NRXPNRX Pharmaceuticals, Inc. 0.20%15.180.0%$167.78m
NVSNovartis AG 0.25%92.420.2%$154.78m
GSKGlaxoSmithKline Plc 0.13%40.150.2%$154.55m
RGENRepligen Corp. 1.95%245.706.8%$95.53m
VTRSViatris, Inc. -1.54%14.070.0%$86.29m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -0.06%126.060.0%$85.37m
NVONovo Nordisk A/S 1.32%92.580.1%$81.36m
RPRXRoyalty Pharma Plc -0.13%38.200.2%$73.90m

Company Profile

SciClone Pharmaceuticals, Inc. (SciClone ) is a global specialty pharmaceutical company. It has a product portfolio of therapies for cancer and infectious diseases. SciClone has in-licensed two products that are part of this international commercial growth strategy, DC Bead and ondansetron RapidFilm. Its DC Bead product candidate is a treatment for liver cancer, which is approved in 40 countries worldwide, including Europe and the United States. Ondansetron RapidFilm is an oral thin film formulation of ondansetron used to treat and prevent nausea and vomiting caused by chemotherapy, radiotherapy and surgery. SCV-07 is being developed for the delay of onset of severe oral mucositis in patients receiving chemoradiation therapy for the treatment of cancers of the head and neck and for the treatment of hepatitis C virus (HCV). Thymalfasin is being developed in an ongoing clinical trial for improvement of Influenza A (H1N1) vaccination.